• (57) 601 215 3714
  • Esta dirección de correo electrónico está protegida contra spambots. Necesita activar JavaScript para visualizarla.

 I. Antecedentes de infección por SARS-CoV-2/COVID-19


  1. Millan-Oñate J, Rodríguez-Morales AJ, Camacho-Moreno G, Mendoza- Ramírez H, Rodríguez-Sabogal IA, Álvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19). Infectio 2020;24(3): 187-192.
  2. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020 doi 10.1016/S0140- 6736(20)30211-7.
  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497-506.
  4. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020.
  5. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment. N Engl J Med. 2020;382:692-94.
  6. Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, Paniz- Mondolfi A, Rabaan A, Sah R, et al. History is repeating itself, a probable zoonotic spillover as a cause of an epidemic: the case of 2019 novel Coronavirus. Infez Med. 2020;28:3-5.
  7. Plowright RK, Parrish CR, McCallum H, Hudson PJ, Ko AI, Graham AL, et al. Pathways to zoonotic spillover. Nat Rev Microbiol. 2017;15:502-10.
  8. Salata C, Calistri A, Parolin C, Palu G. Coronaviruses: a paradigm of new emerging zoonotic diseases. Pathog Dis. 2019;77.
  9. World Health Organization. Novel Coronavirus (2019-nCoV) - Situation report - 7 - 27 January 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200127-sitrep-7-2019--ncov. pdf?sfvrsn=98ef79f5_2020. 2020.
  10. World Health Organization. Pneumonia of unknown cause – China. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/. 2020.
  11. Chen Y, Liu Q, Guo D. Coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020.
  12. Guarner J. Three Emerging Coronaviruses in Two Decades. Am J Clin Pathol. 2020.
  13. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181-92.
  14. World Health Organization;. List of Blueprint priority diseases. 2018.
  15. Villamil-Gomez WE, Sanchez A, Gelis L, Silvera LA, Barbosa J, Otero-Nader O, et al. Fatal human coronavirus 229E (HCoV 229E) and RSV-Related pneumonia in an AIDS patient from Colombia. Travel Med Infect Dis. 2020:101573.
  16. Zhang SF, Tuo JL, Huang XB, Zhu X, Zhang DM, Zhou K, et al. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One. 2018;13:e0191789.
  17. Zhang XM, Kousoulas KG, Storz J. The hemagglutinin/esterase gene of human coronavirus strain OC43: phylogenetic relationships to bovine and murine coronaviruses and influenza C virus. Virology. 1992;186:318-23.
  18. McCloskey B, Heymann DL. SARS to novel coronavirus - old lessons and new lessons. Epidemiol Infect. 2020;148:e22.
  19. World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/ news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). 2020.


  1. Dhama K, Sharun K, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus Disease 2019 – COVID-19. Preprints. 2020;2020030001:(doi: 10.20944/ preprints202003.0001.v1).
  2. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020.
  3. World Health Organization. Novel Coronavirus (2019-nCoV) - Situation report - 10 - 30 January 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov. pdf?sfvrsn=d0b2e480_2. 2020.
  4. Rodriguez-Morales AJ, Gallego V, Escalera-Antezana JP, Mendez CA, Zambrano LI, Franco-Paredes C, et al. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Medicine and Infectious Disease. 2020:101613.
  5. Sao Paulo State Health Secretary. Plan of Response of the Sao Paulo State for the Human Infection due to novel Coronavirus - 2019nCoV. 2020.
  6. da Cunha CA, Cimerman S, Weissmann L, Chebabo A, Bellei NCJ. Informativo da Sociedade Brasileira de Infectologia: Primeiro caso confirmado de doença pelo novo Coronavírus (COVID-19) no Brasil – 26/02/2020. Sociedade Brasileira de Infectologia, Sao Paulo, Brasil. 2020.
  7. Instituto Nacional de Salud. Coronavirus (COVID-19) en Colombia. https:// www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx. 2020.
  8. Cunha CB, Cunha BA. Impact of plague on human history. Infect Dis Clin North Am. 2006;20:253-72, viii.
  9. Snow J. On the Mode of Communication of Cholera. Edinb Med J. 1856;1:668-70.
  10. Cerda L J, Valdivia C G. John Snow, la epidemia de cólera y el nacimiento de la epidemiología moderna. Revista chilena de infectología. 2007;24:331- 34.
  11. Monto AS, Fukuda K. Lessons From Influenza Pandemics of the Last 100 Years. Clin Infect Dis. 2020;70:951-57.
  12. Barry JM. How the Horrific 1918 Flu Spread Across America. Smithsonian Magazine. 2017. https://www.smithsonianmag.com/history/journal-plague-year-180965222/.
  13. World Health Organization. Communicating risk in public health emergencies: a WHO guideline for emergency risk communication (ERC) policy and practice. https://www.who.int/risk-communication/guidance/ download/en/. 2017.
  14. Day M. Covid-19: surge in cases in Italy and South Korea makes pandemic look more likely. BMJ. 2020;368:m751.
  15. Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020;14:125-28.
  16. Giovanetti M, Benvenuto D, Angeletti S, Ciccozzi M. The first two cases of 2019-nCoV in Italy: Where they come from? J Med Virol. 2020.
  17. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020 doi 10.1016/S0140-6736(20)30154-9.
  18. Yang X, Yu Y, Xu J, Shu H, Xia Ja, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020.
  19. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020.
  20. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020 doi 10.1056/NEJMc2001468.
  21. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 doi 10.1056/NEJMoa2001017.
  22. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease. 2020:101623.
  23. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020.
  24. Lombardi A, Bozzi G, Mangioni D, Muscatello A, Peri AM, Taramasso L, et al. Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer. J Hosp Infect. 2020.
  25. Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis. 2020.
  26. Bwire GM, Paulo LS. Coronavirus disease-2019: is fever an adequate screening for the returning travelers? Trop Med Health. 2020;48:14.
  27. Sawano T, Ozaki A, Rodriguez-Morales AJ, Tanimoto T, Sah R. Limiting spread of COVID-19 from cruise ships - lessons to be learnt from Japan. QJM. 2020.
  28. Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020;27.
  29. Cetron M, Simone P. Battling 21st-century scourges with a 14th-century toolbox. Emerg Infect Dis. 2004;10:2053-4.
  30. Cetron M, Landwirth J. Public health and ethical considerations in planning for quarantine. Yale J Biol Med. 2005;78:329-34.
  31. Watts CH, Vallance P, Whitty CJM. Coronavirus: global solutions to prevent a pandemic. Nature. 2020;578:363.
  32. WHO. Current WHO phase of pandemic alert for Pandemic (H1N1) 2009. https://www.who.int/csr/disease/swineflu/phase/en/. 2009.
  33. WHO. Pandemic Influenza Preparedness and Response: A WHO Guidance Document. Geneva: World Health Organization.2009.
  34. WHO. Critical preparedness, readiness and response actions for COVID-19. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/ technical-guidance/critical-preparedness-readiness-and-response-actions-for-COVID-19. 2020.
  35. Parodi SM, Liu VX. From Containment to Mitigation of COVID-19 in the US. JAMA. 2020.
  36. Johns Hopkins University [Internet]. Baltimore; 2020 [actualizado 17 mar 2020; citado17 mar 2020]. Disponible en: https:// gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/ bda7594740fd40299423467b48e9ecf6
  37. Wang C, Liu L, Hao X, et al. Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China. MdRxv [Internet]. 2020 [citado 17 Mar 2020]. doi: 10.1101/2020.03.03.20030593. Disponible en: https://www.medrxiv.org/ content/10.1101/2020.03.03.20030593v1#disqus_thread
  38. Ferguson N, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M, et al. Imperial College COVID-19 Response Team. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand. Imperial College London [Internet]. 2020 [citado 17 Mar 2020]. Doi: 10.25561/77482. Disponible en: https://www.imperial. ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/ Imperial-College-COVID-19-NPI-modelling-16-03-2020.pdf

© 2024 Your Company. All Rights Reserved.